These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10812162)

  • 1. Acute ischemic stroke management.
    Atkinson RP; DeLemos C
    Thromb Res; 2000 May; 98(3):97-111. PubMed ID: 10812162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacotherapy of stroke].
    Bereczki D
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):7-13. PubMed ID: 19731813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The treatment of acute ischemic stroke].
    Csiba L
    Orv Hetil; 2004 Nov; 145(45):2297-301. PubMed ID: 15573895
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical therapy for ischemic stroke: review of intravenous and intra-arterial treatment options.
    Taussky P; Tawk RG; Daugherty WP; Hanel RA
    World Neurosurg; 2011 Dec; 76(6 Suppl):S9-15. PubMed ID: 22182278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of blood pressure and collateral circulation in hyperacute ischemic stroke patients treated with intravenous thrombolysis.
    Rusanen H; Saarinen JT; Sillanpää N
    Cerebrovasc Dis; 2015; 39(2):130-7. PubMed ID: 25660943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breaking up is hard to do: tenecteplase in acute stroke.
    Schwamm LH
    Lancet Neurol; 2015 Apr; 14(4):343-5. PubMed ID: 25726503
    [No Abstract]   [Full Text] [Related]  

  • 9. What's the "hyper" in hyperacute stroke? Strategies to improve outcomes in ischemic stroke patients presenting within 6 hours.
    Bader MK; Palmer S
    AACN Adv Crit Care; 2006; 17(2):194-214. PubMed ID: 16767022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of arterial and venous brain ischemia. Experts' recommendations: stroke management in the intensive care unit].
    Calvet D; Bracard S; Mas JL;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):512-21. PubMed ID: 22647807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activation and thrombolysis for ischemic stroke.
    Medcalf RL; Davis SM
    Int J Stroke; 2012 Jul; 7(5):419-25. PubMed ID: 22463085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous thrombolysis for acute ischemic stroke in the 3- to 4·5-hour window--the Malabar experience.
    Salam KA; Ummer K; Pradeep Kumar VG; Noone ML
    Int J Stroke; 2014 Jun; 9(4):426-8. PubMed ID: 23981667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-based thrombolytic therapy of acute ischemic stroke in Helsinki.
    Lindsberg PJ; Soinne L; Roine RO; Salonen O; Tatlisumak T; Kallela M; Häppölä O; Tiainen M; Haapaniemi E; Kuisma M; Kaste M
    Stroke; 2003 Jun; 34(6):1443-9. PubMed ID: 12738891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolytic therapy for acute ischemic stroke: risks vs benefits.
    Lindbloom EJ
    J Fam Pract; 2003 Oct; 52(10):757, 761. PubMed ID: 14529595
    [No Abstract]   [Full Text] [Related]  

  • 15. 4.5 hours: the new time window for tissue plasminogen activator in stroke.
    Davis SM; Donnan GA
    Stroke; 2009 Jun; 40(6):2266-7. PubMed ID: 19407232
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombolytic treatment of acute ischemic stroke.
    Meschia JF; Miller DA; Brott TG
    Mayo Clin Proc; 2002 Jun; 77(6):542-51. PubMed ID: 12059124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of Early Arterial Recanalization and Tissue Fate in the Selection of Patients With the Greatest Potential to Benefit From Intravenous Tissue-Type Plasminogen Activator.
    Leiva-Salinas C; Patrie JT; Xin W; Michel P; Jovin T; Wintermark M
    Stroke; 2016 Feb; 47(2):397-403. PubMed ID: 26696647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endovascular Therapy in Acute Ischemic Stroke: Challenges and Transition From Trials to Bedside.
    Goyal M; Yu AY; Menon BK; Dippel DW; Hacke W; Davis SM; Fisher M; Yavagal DR; Turjman F; Ross J; Yoshimura S; Miao Z; Bhatia R; Almekhlafi M; Murayama Y; Sohn SI; Saver JL; Demchuk AM; Hill MD
    Stroke; 2016 Feb; 47(2):548-53. PubMed ID: 26742796
    [No Abstract]   [Full Text] [Related]  

  • 19. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.
    Schestatsky P; Picon PD
    Neurology; 2005 Dec; 65(11):1844; author reply 1844. PubMed ID: 16344546
    [No Abstract]   [Full Text] [Related]  

  • 20. The correlation between admission blood glucose and intravenous rt-PA-induced arterial recanalization in acute ischemic stroke: a multi-centre TCD study.
    Saqqur M; Shuaib A; Alexandrov AV; Sebastian J; Khan K; Uchino K
    Int J Stroke; 2015 Oct; 10(7):1087-92. PubMed ID: 26332252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.